Prosecution Insights
Last updated: October 02, 2026

Examiner: WARD, AARON DUREL

Tech Center 1600 • Art Units: 1636 1638

This examiner grants 0% of resolved cases

Performance Statistics

—
Allow Rate
-60.0% vs TC avg
16
Total Applications
—
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

4.4%
§101 Eligibility
21.7%
§102 Novelty
44.6%
§103 Obviousness
21.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18577623 MODULAR PRIME EDITING SYSTEMS FOR GENOME ENGINEERING Non-Final OA UNIVERSITY OF MASSACHUSETTS
17297925 THERAPEUTIC GENE EDITING FOR ELANE-ASSOCIATED DISEASE Non-Final OA UNIVERSITY OF MASSACHUSETTS
18274075 TARGETED RETROVIRAL INTEGRATION FOR TREATMENT OF GENETIC DISORDERS Non-Final OA Ohio State Innovation Foundation
18248933 ENGINEERED CAS ENDONUCLEASE VARIANTS FOR IMPROVED GENOME EDITING Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
17731195 Sensors for Aromatic Compounds and Methods of Making and Using Same Non-Final OA WASHINGTON UNIVERSITY
18455380 PROGRAMMABLE RNA WRITING USING CRISPR EFFECTORS AND TRANS-SPLICING TEMPLATES Non-Final OA Massachusetts Institute of Technology
18365176 HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION Non-Final OA The Curators of the University of Missouri
18463837 DE NOVO ENGINEERING OF A BACTERIAL LIFESTYLE PROGRAM Non-Final OA The Board of Trustees of the University of Illinois
17996165 SYSTEM FOR THREE-WAY COMBINATORIAL CRISPR SCREENS FOR ANALYSING TARGET INTERACTIONS AND METHODS THEREOF Non-Final OA THE UNIVERSITY OF HONG KONG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month